Xu Y - Search Results

1

Consensus Guidelines for the Use of Fluorescence Imaging in Hepatobiliary Surgery.

Wang X, Teh CSC, Ishizawa T, Aoki T, Cavallucci D, Lee SY, Panganiban KM, Perini MV, Shah SR, Wang H, Xu Y, Suh KS, Kokudo N. Wang X, et al. Among authors: xu y. Ann Surg. 2021 Jul 1;274(1):97-106. doi: 10.1097/SLA.0000000000004718. Ann Surg. 2021. PMID: 33351457

2

Living donor liver transplantation using dual grafts: Experience and lessons learned from cases worldwide.

Xu Y, Chen H, Yeh H, Wang H, Leng J, Dong J. Xu Y, et al. Liver Transpl. 2015 Nov;21(11):1438-48. doi: 10.1002/lt.24315. Epub 2015 Oct 10. Liver Transpl. 2015. PMID: 26336078 Free article. Review.

3

Robotic radical resection for hilar cholangiocarcinoma: perioperative and long-term outcomes of an initial series.

Xu Y, Wang H, Ji W, Tang M, Li H, Leng J, Meng X, Dong J. Xu Y, et al. Surg Endosc. 2016 Jul;30(7):3060-70. doi: 10.1007/s00464-016-4925-7. Epub 2016 May 18. Surg Endosc. 2016. PMID: 27194255

4

Indocyanine green fluorescence image-guided total laparoscopic living donor right hepatectomy: The first case report from Mainland China.

Meng X, Wang H, Xu Y, Chen M, Duan W, Lu S. Meng X, et al. Among authors: xu y. Int J Surg Case Rep. 2018;53:406-409. doi: 10.1016/j.ijscr.2018.11.033. Epub 2018 Nov 22. Int J Surg Case Rep. 2018. PMID: 30567056 Free PMC article.

5

Laparoscopic anatomical liver resection guided by real-time indocyanine green fluorescence imaging: experience and lessons learned from the initial series in a single center.

Xu Y, Chen M, Meng X, Lu P, Wang X, Zhang W, Luo Y, Duan W, Lu S, Wang H. Xu Y, et al. Surg Endosc. 2020 Oct;34(10):4683-4691. doi: 10.1007/s00464-020-07691-5. Epub 2020 Jun 4. Surg Endosc. 2020. PMID: 32500459

6

Surgeons' response to COVID-19: modified workflow to adapt to the new normal.

Xu Y, Pan Y, Wang X, Liu G, Liu Y, Lu S. Xu Y, et al. Br J Surg. 2020 Aug;107(9):e318-e319. doi: 10.1002/bjs.11773. Epub 2020 Jul 8. Br J Surg. 2020. PMID: 32639030 Free PMC article. No abstract available.

7

Surgery After Conversion Therapy With PD-1 Inhibitors Plus Tyrosine Kinase Inhibitors Are Effective and Safe for Advanced Hepatocellular Carcinoma: A Pilot Study of Ten Patients.

Zhang W, Hu B, Han J, Wang Z, Ma G, Ye H, Yuan J, Cao J, Zhang Z, Shi J, Chen M, Wang X, Xu Y, Cheng Y, Tian L, Wang H, Lu S. Zhang W, et al. Among authors: xu y. Front Oncol. 2021 Oct 19;11:747950. doi: 10.3389/fonc.2021.747950. eCollection 2021. Front Oncol. 2021. PMID: 34737958 Free PMC article.

8

Perioperative and long-term outcomes of liver resection for hepatitis B virus-related hepatocellular carcinoma without versus with hepatic inflow occlusion: study protocol for a prospective randomized controlled trial.

Xu Y, Chen J, Wang H, Zheng H, Feng D, Zhang A, Leng J, Duan W, Yang Z, Chen M, Shi X, Cai S, Ji W, Jiang K, Zhang W, Chen Y, Gu W, Dong J, Lu S. Xu Y, et al. Trials. 2016 Oct 11;17(1):492. doi: 10.1186/s13063-016-1621-9. Trials. 2016. PMID: 27724929 Free PMC article. Clinical Trial.

9

Precision in liver surgery.

Dong J, Yang S, Zeng J, Cai S, Ji W, Duan W, Zhang A, Ren W, Xu Y, Tan J, Bu X, Zhang N, Wang X, Wang X, Meng X, Jiang K, Gu W, Huang Z. Dong J, et al. Among authors: xu y. Semin Liver Dis. 2013 Aug;33(3):189-203. doi: 10.1055/s-0033-1351781. Epub 2013 Aug 13. Semin Liver Dis. 2013. PMID: 23943100 Review. Danish, English.

10

Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis.

Leng JJ, Xu YZ, Dong JH. Leng JJ, et al. ANZ J Surg. 2016 Oct;86(10):816-820. doi: 10.1111/ans.12803. Epub 2014 Aug 3. ANZ J Surg. 2016. PMID: 25088384 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67,189 results

Search Page